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Carney’s complex is a rare inherited disease of multicentric tumours of
multiple organs. It is inherited in autosomal dominant fashion. Primary
pigmented nodular adrenocortical dysplasia (PPNAD) is a component of
Carney’s complex [1].
Primary pigmented nodular adrenocortical dysplasia is an exceedingly
rare cause of Cushing’s syndrome in young adults. It is characterized by
non-adrenocorticotropic hormone-dependent hypersecretion of cortisol
by multiple, pigmented nodules of hyperplastic adrenocortical cells. Treat-
ment for PPNAD involves bilateral adrenalectomy because of high recur-
rence risk after unilateral or partial adrenalectomy. Cohen et al. reported
a successful pregnancy after unilateral adrenalectomy for PPNAD [2]. Kid-
ney stones were reported in about 15% of Cushing’s syndrome cases [3].
The susceptibility of the patients to nephrolithiasis is probably due to the
synergic effect of several lithogenic factors, such as increased urinary
excretion of calcium, phosphorus, potassium, uric acid, cystine, and oxalate
and decreased urinary excretion of citrate. Chronically elevated urinary
excretion of these elements represents a direct and/or indirect risk factor
for kidney stone formation. Unlike these factors, citrate and potassium
are protective factors by inhibiting urinary crystal formation. The preva-
lence of nephrolithiasis in the patients remained still higher than in the
general population after disease remission, even if lithogenic factors had
normalized [4]. All Cushing’s syndrome patients must be evaluated very
carefully for lithogenic factors and kidney disease. 
Here we present a successful pregnancy three years after bilateral
adrenalectomy due to Cushing’s syndrome secondary to Carney complex
in a 28-year-old nulliparous woman.
A 24-year-old previously healthy female presented with a 4-week his-
tory of fatigue, weight gain and alopecia. Clinical examination revealed
central obesity, plethora, moon face, buffalo hump, atrophy in muscles of
extremities, pigmented skin lesion, arrhythmia and severe hypertension.
Serum ACTH level was low and cortisol was high at 09:00 h. Serum corti-
sol at 09:00 h also failed to suppress with either low-dose or high-dose
dexamethasone suppression tests according to standard criteria [5]. Her
plasma electrolytes, fasting glucose, thyroid function tests and liver func-
tion tests were in the normal range. Electrocardiogram (ECG) showed sinus
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which subsequently responded well to propafenone
150 mg tid. Echocardiogram was reported to be nor-
mal. Magnetic resonance imaging (MRI) of pituitary
and hypothalamus revealed a cyst of Rathke’s cleft
around a millimetre in size. An abdominopelvic MRI
showed bilateral multinodular appearance in adre-
nal glands, supporting a diagnosis of hyperplasia,
and bilateral renal calculi. She had a right femoral
neck fracture secondary to osteoporosis whilst
under therapy for Cushing syndrome. Surgery for
this fracture was planned after bilateral adrenalec-
tomy. Preoperatively she received metyrapone for
6 weeks in order to normalize her serum cortisol in
preparation for surgery. The pathology report for
the bilateral adrenalectomy specimen revealed
PPNAD. This pathological finding, combined with
the presence of pigmented skin lesions, established
the diagnosis of Carney complex. The post-opera-
tive course of the patient was unremarkable while
she was on prednisolone 5 mg bid and fludrocorti-
sone 0.1 mg daily replacement therapy. A prosthe-
sis for femoral neck fracture was inserted 6 months
after bilateral adrenalectomy. She subsequently had
extracorporeal shock wave lithotripsy (ESWL) for
multiple calculi. One year later her weight was
decreased to 51 kg and 2 years later she had nor-
mal serum Ca, P and PTH levels along with a bone
density which was appropriate for her age. She had
regular menses 1 year after bilateral adrenalecto-
my and she was married at 26 years. Her ACTH lev-
els were stable and Nelson syndrome did not com-
plicate the course.
She got pregnant under replacement therapy at
the age of 27 years. She had an uncomplicated
pregnancy until 32 weeks of gestation. At this stage
she was hospitalized for the diagnosis of suspect-
ed preterm premature rupture of membranes
(PPROM) and intrauterine growth retardation
(IUGR). Preterm premature rupture of membranes
was not confirmed but the fetus was monitored for
IUGR. The fludrocortisone dose was stable through-
out pregnancy but the prednisolone dose was
increased 1.5 times at the third trimester. Signs and
symptoms of neither hypo/hypercortisolism nor
electrolyte imbalance were noted during pregnan-
cy. Gestational diabetes did not develop. She was
given a stress dose of 100 mg of IV hydrocortisone
before caesarean section for breech presentation
and hydrocortisone weaning was scheduled for the
following 3 days. The dose regimen prior to preg-
nancy for fludrocortisone and prednisolone was
resumed 3 days after the operation. A 2850 g
healthy male infant was delivered at gestational
age of 37 years. No fetal or maternal complications
were observed.
Although women with Cushing’s syndrome rarely
conceive, successful pregnancies have been report-
ed [6]. But maternal and fetal mortality and mor-
bidity rates of such pregnancies are high [7]. Such
mothers are prone to diabetes mellitus, hyperten-
sive disorders of pregnancy, cardiac failure, pul-
monary oedema and even death, and their fetus-
es are also prone to abortion, and intrauterine and
neonatal death [7]. 
Primary pigmented nodular adrenocortical dys-
plasia is a rare cause of Cushing’s syndrome and is
generally treated with bilateral total adrenalecto-
my due to high recurrence risk following partial or
unilateral adrenalectomy. The main risks of bilat-
eral adrenalectomy are hypoadrenalism and adre-
nal crisis. Pregnancy planning in patients with
PPNAD requires meticulous multidisciplinary med-
ical care and detailed patient information because
hypoadrenalism after operative treatment may also
be associated with maternal and fetal complica-
tions during pregnancy and puerperium. Cohen et
al. reported a PPNAD case managed with unilater-
al adrenalectomy in order to preserve adrenal func-
tion for an anticipated pregnancy [2]. The pregnancy
was uneventful and the fetal development was nor-
mal without any steroid therapy. But he also
emphasized the need for long-term meticulous fol-
low-up due to the fact that remission might be tem-
porary. The long-term outcome of this case was not
available. 
Successful pregnancy outcomes in women with
Addison’s disease have been reported by several
authors since the mid-1960s [8]. Many cases of
bilateral adrenalectomy have also been reported,
but no data related to their fertility after the pro-
cedure are available in the English literature. On the
other hand, scarce case reports of bilateral adrena-
lectomy during pregnancy are available. Berends et
al. first reported a case of bilateral adrenalectomy
due to bilateral pheochromocytoma during preg-
nancy but they did not give further details on post-
operative follow-up of the case [9]. Phupong et al.
also reported a case of bilateral adrenalectomy dur-
ing pregnancy [10]. But this case received gluco-
corticoid replacement only and a growth-retarded
fetus was delivered due to fetal compromise at ges-
tational age of 31 years. Glucocorticoid treatment
during pregnancy reduces birth weight in animal
models, including non-human primates and
humans [11-14]. Birth weight reduction is most
notable when glucocorticoids are administered in
the latter stages of pregnancy [12], presumably
reflecting the catabolic actions of these steroids,
actions most likely to become manifest as reduced
birth weight during the period of maximum fetal
somatic growth. In some studies, antenatal gluco-
corticoids are associated with a reduction in birth
weight [13]. Compared with betamethasone and
dexamethasone, which cross the placental barrier
in ratios of 3 : 1 and 2 : 1, respectively, only 10% of
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prednisolone crosses the placenta to reach the
fetus. Glucocorticoid treatment is known to accel-
erate organ maturation at the expense of organ
size, so it was also reassuring to find no difference
in birth weight and head circumference [14].  
Growth retardation also complicated our case
despite additional mineralocorticoid replacement.
Although the patient underwent physiological pred-
nisolone replacement therapy, steroid replacement
may cause growth retardation. The patient was not
married and was not considering pregnancy just
before the operation and an unexpected fracture
of the femoral neck necessitated definitive curative
treatment before she got married and pregnant. 
Signs of both inadequate and excessive steroid
treatment such as lethargy and hypotension dur-
ing pregnancy must be monitored in these patients
because plasma renin activity and plasma cortisol
level are not used for dose titration of prednisolone
and fludrocortisone in pregnancy [15]. Our case was
normotensive and developed no electrolyte imbal-
ance throughout pregnancy under both glucocorti-
coid and mineralocorticoid therapy. In spite of the
absence of signs of lethargy in our case, the dose
of prednisolone was increased 1.5 times at the third
trimester in order to catch up with normally increas-
ing serum cortisol levels as pregnancy progresses.
Addisonian crisis is a life-threatening event in preg-
nant women and usually accompanies stressful
conditions such as hyperemesis gravidarum, infec-
tion and labour. A stress dose of hydrocortisone,
owing to its glucocorticoid and mineralocorticoid
activities, should be administered in such situa-
tions. Following the stress dose and three-day
hydrocortisone weaning in the postoperative peri-
od, the dose regimen prior to pregnancy was
resumed in our case. 
Maternal and fetal successful outcomes could
also be obtained with meticulous multidisciplinary
management in cases which have undergone bilat-
eral adrenalectomy secondary to PPNAD.
References
1.  Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VLW.
The complex of myxomas, spotty pigmentation and
endocrine overactivity. Medicine 1985; 64: 270-83. 
2. Cohen O, Bogat S, Dolitzki M, Karasik A. Successful
pregnancy after unilateral adrenalectomy in a case of
primary pigmented adrenocortical disease. J Matern Fetal
Neonatal Med 2005; 17: 161-3. 
3. Ross EJ, Marshall-Jones P, Friedman M. Cushing’s
syndrome: diagnostic criteria. Q J Med 1966; 35: 149-92. 
4.  Faggiano A, Pivonello R, Melis D, et al. Nephrolithiasis in
Cushing’s disease: prevalence, etiopathogenesis, and
modification after disease cure. J Clin Endocrinol Metab
2003; 88: 2076-80. 
5.  Trainer PJ, Grossman A. The diagnosis and differential
diagnosis of Cushing’s syndrome. Clin Endocrinol 1991;
34: 317-30. 
6. Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, et al.
Menstrual abnormalities in women with Cushing’s
disease are correlated with hypercortisolemia rather than
raised circulating androgen levels. J Clin Endocrinol Metab
1998; 83: 3083-8.
7.  Chico A, Manzanares JM, Halperin I, Martinez de Osaba
MJ, Adelantado J, Webb SM. Cushing’s disease and
pregnancy: report of six cases. Eur J Obstet Gynecol
Reprod Biol 1996; 64: 143-6.
8. Ambrosi B, Barbetta L, Morricone L. Diagnosis and
management of Addison’s disease during pregnancy. 
J Endocrinol Invest 2004; 26: 695-702.
9.  Berends FJ, Harst EV, Giraudo G, et al. Safe retroperitoneal
endoscopic resection of pheochromocytomas. World 
J Surg 2002; 26: 527-31.
10.  Phupong V, Witoonpanich P, Snabboon T, Tharavej C,
Ultchaswadi P . Bilateral pheochromocytoma during
pregnancy. Arch Gynecol Obstet 2005; 271: 276-9.
11.  Reinisch JM, Simon NG, Karow WG, Gandelman R.
Prenatal exposure to prednisone in humans and animals
retards intrauterine growth. Science 1978; 202: 436-8.
12. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR.
Glucocorticoid exposure in late gestation permanently
programmes rat hepatic phosphoenolpyruvate carboxy  -
kinase and glucocorticoid receptor expression and causes
glucose intolerance in adult offspring. J Clin Invest 1998;
101: 2174-81.
13.  French NP, Hagan R, Evans SF, Godfrey M, Newnham JP .
Repeated antenatal corticosteroids: size at birth and
subsequent development. Am J Obstet Gynecol 1999;
180: 114-21.
14. Miller NM, Williamson C, Fisk NM, Glover V. Infant cortisol
response after prolonged antenatal prednisolone
treatment. BJOG 2004; 111: 1471-4. 
15.  Trainer PJ. Corticosteroids and pregnancy. Semin Reprod
Med 2002; 20: 375-80.